Tempest Therapeutics Secures $50M Equity Purchase Agreement With Lincoln Park Capital
On August 13, 2026, Tempest Therapeutics, Inc., a Delaware corporation (the "Company"), entered into a purchase agreement (the "Purchase Agreement") and a registration rights agreement (the
Tempest Therapeutics got $50 million in cash from an investor to help pay for their work. This shows someone believes in the company enough to give them money, which is helpful when a company needs fuel to keep going.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.